constitute 发表于 2025-3-25 04:23:05

Submitted on: 09 June 2017.
Revised on: 22 September 2017.
Accepted on: 25 October 2017.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD

知识 发表于 2025-3-25 09:11:01

http://reply.papertrans.cn/1/72/7104/7104-22.png

寡头政治 发表于 2025-3-25 13:32:44

http://reply.papertrans.cn/1/72/7104/7104-23.png

细查 发表于 2025-3-25 15:52:22

Submitted on: 08 February 2017.
Revised on: 04 May 2017.
Accepted on: 03 June 2017.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD

Optimum 发表于 2025-3-25 21:42:40

Submitted on: 13 December 2005.
Revised on: 25 January 2006.
Accepted on: 21 March 2006.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD

倾听 发表于 2025-3-26 02:15:14

Submitted on: 19 November 2006.
Revised on: 19 January 2007.
Accepted on: 01 February 2007.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD

Homocystinuria 发表于 2025-3-26 05:59:13

Submitted on: 23 May 2009.
Revised on: 22 August 2009.
Accepted on: 19 October 2009.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD

inspiration 发表于 2025-3-26 08:44:03

http://reply.papertrans.cn/1/72/7104/7104-28.png

不能强迫我 发表于 2025-3-26 16:22:20

Submitted on: 14 September 2018.
Revised on: 07 January 2019.
Accepted on: 08 February 2019.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD

模范 发表于 2025-3-26 20:00:42

Submitted on: 20 December 2020.
Revised on: 05 February 2021.
Accepted on: 06 March 2021.

___________________Current Vascular Pharmacology---BENTHAM SCIENCE PUBL LTD
页: 1 2 [3] 4
查看完整版本: SCIE期刊Current Vascular Pharmacology 2024/2025影响因子:2.877 (CURR VASC PHARMACOL) (1570-1611). (PHARMACOLOGY & PHARMACY)(药理